What's in Daryoush Hamidi Alamdari, PhD's pipeline?

Daryoush Hamidi Alamdari, PhD has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Daryoush Hamidi Alamdari, PhD's portfolio?

Top competitors by shared drug class: Centre Francois Baclesse, Federico II University, SolasCure Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/daryoush-hamidi-alamdari-phd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Daryoush Hamidi Alamdari, PhD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Daryoush Hamidi Alamdari, PhD pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Wound Healing Gel	Wound Healing Gel	phase 3	Wound healing agent		Dermatology

Therapeutic area mix

Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Centre Francois Baclesse · 1 shared drug class
Federico II University · 1 shared drug class
SolasCure Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Daryoush Hamidi Alamdari, PhD:

Cite this brief

Drug Landscape (2026). Daryoush Hamidi Alamdari, PhD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/daryoush-hamidi-alamdari-phd. Accessed 2026-05-17.